# Bentley Systems Inc: financial statements, quarterly

BSY · Nasdaq · CIK 1031308 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bsy.md) · [Financials](/companies/bsy/financials.md) · [Filings](/companies/bsy/filings.md) · [Insiders](/companies/bsy/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bsy/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [307](/filings/0001031308-24-000012.md) | [311 d](/filings/0001031308-26-000007.md) | [338](/filings/0001031308-25-000004.md) | [330](/filings/0001031308-25-000007.md) | [335](/filings/0001031308-25-000015.md) | [350 d](/filings/0001031308-26-000007.md) | [371](/filings/0001031308-26-000017.md) | [364](/filings/0001031308-26-000023.md) | [376](/filings/0001031308-25-000015.md) | [392 d](/filings/0001031308-26-000007.md) | [424](/filings/0001031308-26-000017.md) | [411](/filings/0001031308-26-000023.md) |
| Cost of revenue | $m | [64.7](/filings/0001031308-24-000012.md) | [67.8 d](/filings/0001031308-26-000007.md) | [61.8](/filings/0001031308-25-000004.md) | [63.2](/filings/0001031308-25-000007.md) | [64.8](/filings/0001031308-25-000015.md) | [67.9 d](/filings/0001031308-26-000007.md) | [65.7](/filings/0001031308-26-000017.md) | [68.8](/filings/0001031308-26-000023.md) | [72.2](/filings/0001031308-25-000015.md) | [70.9 d](/filings/0001031308-26-000007.md) | [73.8](/filings/0001031308-26-000017.md) | [74.0](/filings/0001031308-26-000023.md) |
| Gross profit | $m | [242](/filings/0001031308-24-000012.md) | [243 d](/filings/0001031308-26-000007.md) | [276](/filings/0001031308-25-000004.md) | [267](/filings/0001031308-25-000007.md) | [270](/filings/0001031308-25-000015.md) | [282 d](/filings/0001031308-26-000007.md) | [305](/filings/0001031308-26-000017.md) | [295](/filings/0001031308-26-000023.md) | [303](/filings/0001031308-25-000015.md) | [321 d](/filings/0001031308-26-000007.md) | [350](/filings/0001031308-26-000017.md) | [337](/filings/0001031308-26-000023.md) |
| Research and development | $m | [65.5](/filings/0001031308-24-000012.md) | [71.2 d](/filings/0001031308-26-000007.md) | [68.4](/filings/0001031308-25-000004.md) | [65.7](/filings/0001031308-25-000007.md) | [70.1](/filings/0001031308-25-000015.md) | [77.1 d](/filings/0001031308-26-000007.md) | [72.5](/filings/0001031308-26-000017.md) | [75.4](/filings/0001031308-26-000023.md) | [78.8](/filings/0001031308-25-000015.md) | [81.0 d](/filings/0001031308-26-000007.md) | [83.0](/filings/0001031308-26-000017.md) | [82.1](/filings/0001031308-26-000023.md) |
| Operating income | $m | [73.7](/filings/0001031308-24-000012.md) | [37.8 d](/filings/0001031308-26-000007.md) | [91.9](/filings/0001031308-25-000004.md) | [80.2](/filings/0001031308-25-000007.md) | [68.6](/filings/0001031308-25-000015.md) | [61.4 d](/filings/0001031308-26-000007.md) | [115](/filings/0001031308-26-000017.md) | [84.4](/filings/0001031308-26-000023.md) | [84.5](/filings/0001031308-25-000015.md) | [78.5 d](/filings/0001031308-26-000007.md) | [126](/filings/0001031308-26-000017.md) | [88.6](/filings/0001031308-26-000023.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [16.5](/filings/0001031308-24-000012.md) | [(165) d](/filings/0001031308-26-000007.md) | [22.2](/filings/0001031308-25-000004.md) | [5.3](/filings/0001031308-25-000007.md) | [16.5](/filings/0001031308-25-000015.md) | [14.6 d](/filings/0001031308-26-000007.md) | [20.5](/filings/0001031308-26-000017.md) | [8.9](/filings/0001031308-26-000023.md) | [26.3](/filings/0001031308-25-000015.md) | [17.4 d](/filings/0001031308-26-000007.md) | [23.2](/filings/0001031308-26-000017.md) | [16.6](/filings/0001031308-26-000023.md) |
| Net income | $m | [53.0](/filings/0001031308-24-000012.md) | [180 d](/filings/0001031308-26-000007.md) | [70.3](/filings/0001031308-25-000004.md) | [72.0](/filings/0001031308-25-000007.md) | [42.3](/filings/0001031308-25-000015.md) | [50.1 d](/filings/0001031308-26-000007.md) | [91.4](/filings/0001031308-26-000017.md) | [70.5](/filings/0001031308-26-000023.md) | [57.4](/filings/0001031308-25-000015.md) | [58.6 d](/filings/0001031308-26-000007.md) | [95.4](/filings/0001031308-26-000017.md) | [78.6](/filings/0001031308-26-000023.md) |
| Diluted EPS | $ per share | [0.16](/filings/0001031308-24-000012.md) | not reported | [0.22](/filings/0001031308-25-000004.md) | [0.22](/filings/0001031308-25-000007.md) | [0.13](/filings/0001031308-25-000015.md) | not reported | [0.28](/filings/0001031308-26-000017.md) | [0.22](/filings/0001031308-26-000023.md) | [0.18](/filings/0001031308-25-000015.md) | not reported | [0.30](/filings/0001031308-26-000017.md) | [0.25](/filings/0001031308-26-000023.md) |
| Basic EPS | $ per share | [0.17](/filings/0001031308-24-000012.md) | not reported | [0.22](/filings/0001031308-25-000004.md) | [0.23](/filings/0001031308-25-000007.md) | [0.13](/filings/0001031308-25-000015.md) | not reported | [0.29](/filings/0001031308-26-000017.md) | [0.22](/filings/0001031308-26-000023.md) | [0.18](/filings/0001031308-25-000015.md) | not reported | [0.31](/filings/0001031308-26-000017.md) | [0.25](/filings/0001031308-26-000023.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [67.0](/filings/0001031308-23-000011.md) | [68.4](/filings/0001031308-25-000002.md) | [142](/filings/0001031308-24-000004.md) | [51.3](/filings/0001031308-24-000009.md) | [72.2](/filings/0001031308-24-000012.md) | [64.0](/filings/0001031308-26-000007.md) | [83.6](/filings/0001031308-25-000004.md) | [89.6](/filings/0001031308-25-000007.md) | [165](/filings/0001031308-25-000015.md) | [123](/filings/0001031308-26-000023.md) | [105](/filings/0001031308-26-000017.md) | [147](/filings/0001031308-26-000023.md) |
| Current assets | $m | [374](/filings/0001031308-23-000011.md) | [420](/filings/0001031308-25-000002.md) | [474](/filings/0001031308-24-000004.md) | [387](/filings/0001031308-24-000009.md) | [404](/filings/0001031308-24-000012.md) | [442](/filings/0001031308-26-000007.md) | [446](/filings/0001031308-25-000004.md) | [440](/filings/0001031308-25-000007.md) | [527](/filings/0001031308-25-000015.md) | [539](/filings/0001031308-26-000023.md) | [518](/filings/0001031308-26-000017.md) | [588](/filings/0001031308-26-000023.md) |
| Total assets | $m | [3,135](/filings/0001031308-23-000011.md) | [3,320](/filings/0001031308-25-000002.md) | [3,354](/filings/0001031308-24-000004.md) | [3,257](/filings/0001031308-24-000009.md) | [3,396](/filings/0001031308-24-000012.md) | [3,400](/filings/0001031308-26-000007.md) | [3,403](/filings/0001031308-25-000004.md) | [3,423](/filings/0001031308-25-000007.md) | [3,464](/filings/0001031308-25-000015.md) | [3,555](/filings/0001031308-26-000023.md) | [3,524](/filings/0001031308-26-000017.md) | [3,583](/filings/0001031308-26-000023.md) |
| Current liabilities | $m | [681](/filings/0001031308-23-000011.md) | [760](/filings/0001031308-25-000002.md) | [838](/filings/0001031308-24-000004.md) | [786](/filings/0001031308-24-000009.md) | [782](/filings/0001031308-24-000012.md) | [814](/filings/0001031308-26-000007.md) | [906](/filings/0001031308-25-000004.md) | [858](/filings/0001031308-25-000007.md) | [860](/filings/0001031308-25-000015.md) | [960](/filings/0001031308-26-000023.md) | [1,007](/filings/0001031308-26-000017.md) | [988](/filings/0001031308-26-000023.md) |
| Total liabilities | $m | [2,443](/filings/0001031308-23-000011.md) | [2,436](/filings/0001031308-25-000002.md) | [2,421](/filings/0001031308-24-000004.md) | [2,273](/filings/0001031308-24-000009.md) | [2,362](/filings/0001031308-24-000012.md) | [2,359](/filings/0001031308-26-000007.md) | [2,305](/filings/0001031308-25-000004.md) | [2,261](/filings/0001031308-25-000007.md) | [2,269](/filings/0001031308-25-000015.md) | [2,366](/filings/0001031308-26-000023.md) | [2,298](/filings/0001031308-26-000017.md) | [2,381](/filings/0001031308-26-000023.md) |
| Long-term debt | $m | [1,581](/filings/0001031308-23-000011.md) | [1,518](/filings/0001031308-25-000002.md) | [1,425](/filings/0001031308-24-000004.md) | [1,335](/filings/0001031308-24-000009.md) | [1,419](/filings/0001031308-24-000012.md) | [1,388](/filings/0001031308-26-000007.md) | [1,244](/filings/0001031308-25-000004.md) | [1,246](/filings/0001031308-25-000007.md) | [1,247](/filings/0001031308-25-000015.md) | [1,249](/filings/0001031308-26-000023.md) | [1,115](/filings/0001031308-26-000017.md) | [1,210](/filings/0001031308-26-000023.md) |
| Current portion of debt | $m | [8.8](/filings/0001031308-23-000011.md) | [10.0](/filings/0001031308-25-000002.md) | [10.0](/filings/0001031308-24-000004.md) | [0.0](/filings/0001031308-24-000009.md) | [0.0](/filings/0001031308-24-000012.md) | [0.0](/filings/0001031308-26-000007.md) | [0.0](/filings/0001031308-25-000004.md) | [0.0](/filings/0001031308-25-000007.md) | [0.0](/filings/0001031308-25-000015.md) | [0.0](/filings/0001031308-26-000023.md) | [0.0](/filings/0001031308-26-000017.md) | [6.9](/filings/0001031308-26-000023.md) |
| Shareholders' equity | $m | [692](/filings/0001031308-24-000012.md) | [883](/filings/0001031308-25-000002.md) | [933](/filings/0001031308-25-000007.md) | [985](/filings/0001031308-25-000015.md) | [1,034](/filings/0001031308-25-000015.md) | [1,041](/filings/0001031308-26-000007.md) | [1,098](/filings/0001031308-25-000004.md) | [1,162](/filings/0001031308-25-000007.md) | [1,195](/filings/0001031308-25-000015.md) | [1,189](/filings/0001031308-26-000023.md) | [1,226](/filings/0001031308-26-000017.md) | [1,202](/filings/0001031308-26-000023.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [72.8 d](/filings/0001031308-24-000012.md) | [87.1 d](/filings/0001031308-26-000007.md) | [205](/filings/0001031308-25-000004.md) | [62.6 d](/filings/0001031308-25-000007.md) | [86.1 d](/filings/0001031308-25-000015.md) | [81.6 d](/filings/0001031308-26-000007.md) | [219](/filings/0001031308-26-000017.md) | [61.1 d](/filings/0001031308-26-000023.md) | [116 d](/filings/0001031308-25-000015.md) | [142 d](/filings/0001031308-26-000007.md) | [193](/filings/0001031308-26-000017.md) | [71.5 d](/filings/0001031308-26-000023.md) |
| Capital expenditure | $m | [7.7 d](/filings/0001031308-24-000012.md) | [6.1 d](/filings/0001031308-26-000007.md) | [3.6](/filings/0001031308-25-000004.md) | [3.1 d](/filings/0001031308-25-000007.md) | [1.8 d](/filings/0001031308-25-000015.md) | [5.5 d](/filings/0001031308-26-000007.md) | [3.0](/filings/0001031308-26-000017.md) | [4.1 d](/filings/0001031308-26-000023.md) | [5.7 d](/filings/0001031308-25-000015.md) | [5.4 d](/filings/0001031308-26-000007.md) | [5.6](/filings/0001031308-26-000017.md) | [7.7 d](/filings/0001031308-26-000023.md) |
| Dividends paid | $m | [14.8 d](/filings/0001031308-24-000012.md) | [14.8 d](/filings/0001031308-26-000007.md) | [17.9](/filings/0001031308-25-000004.md) | [18.0 d](/filings/0001031308-25-000007.md) | [18.1 d](/filings/0001031308-25-000015.md) | [18.1 d](/filings/0001031308-26-000007.md) | [21.2](/filings/0001031308-26-000017.md) | [21.3 d](/filings/0001031308-26-000023.md) | [21.3 d](/filings/0001031308-25-000015.md) | [21.2 d](/filings/0001031308-26-000007.md) | [21.2](/filings/0001031308-26-000017.md) | [21.2 d](/filings/0001031308-26-000023.md) |
| Share repurchases | $m | [0.0 d](/filings/0001031308-24-000012.md) | [0.0 d](/filings/0001031308-26-000007.md) | [15.0](/filings/0001031308-25-000004.md) | [22.5 d](/filings/0001031308-25-000007.md) | [8.3 d](/filings/0001031308-25-000015.md) | [18.6 d](/filings/0001031308-26-000007.md) | [30.0](/filings/0001031308-26-000017.md) | [20.0 d](/filings/0001031308-26-000023.md) | [15.0 d](/filings/0001031308-25-000015.md) | [60.0 d](/filings/0001031308-26-000007.md) | [40.0](/filings/0001031308-26-000017.md) | [85.1 d](/filings/0001031308-26-000023.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [325](/filings/0001031308-23-000011.md) | [331](/filings/0001031308-24-000004.md) | [332](/filings/0001031308-24-000009.md) | [333](/filings/0001031308-24-000012.md) | [334](/filings/0001031308-25-000004.md) | [334](/filings/0001031308-25-000007.md) | [334](/filings/0001031308-25-000015.md) | [333](/filings/0001031308-26-000017.md) | [333](/filings/0001031308-26-000023.md) | [333](/filings/0001031308-25-000015.md) | [322](/filings/0001031308-26-000017.md) | [319](/filings/0001031308-26-000023.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.